Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaintel Regulatory News (MAI)

Share Price Information for Maintel (MAI)

Share Price is delayed by 15 minutes
Get Live Data
92.50    0.00 (0.00%)
Bid:
85.00
Ask:
100.00
Spread: 15.00 (17.647%)
Market Cap: £13.28m
MAI Live PriceLast checked at - London Stock Exchange

Intraday Maintel Share Chart

Director Appointment

1 Oct 2021 07:00

RNS Number : 6302N
Maintel Holdings PLC
01 October 2021
 

Maintel Holdings Plc ("Maintel" or the "Company")

Director Appointment

 

Maintel Holdings Plc, a leading provider of cloud, security and managed communication services, is pleased to announce the appointment of Carol Thompson as a Non-Executive Director with immediate effect.

Mrs. Thompson is a Fellow of the Chartered Institute of Management Accountants and has over 20 years' experience in Senior Finance roles, gained in both private and public companies. Between 2011 and 2015 she held the position of Chief Financial Officer at SSP plc, the global software company. Prior to SSP plc, she was Chief Financial Officer at Electricity North West, and has also served as Finance Director at The Tote, and at Stanley Leisure plc, acquiring significant knowledge of company strategy, mergers and acquisitions, and refinancing. Most recently she has focused on building a portfolio of non-executive and advisory roles in the technology, regulatory, legal and professional services sectors.

Commenting on her appointment, John Booth, Non-Executive Chairman of the Company said:

"I am delighted to welcome Carol to the board. I am sure the wealth of financial experience and insight in our sector that she brings will be a great benefit to the Company as we look to deliver on our future development and growth."

 

For further information please contact:

Ioan MacRae, Chief Executive Officer  0344 871 1122

Dan Davies, Chief Technology Officer

finnCap 

Jonny Franklin-Adams / Kate Bannatyne (Corporate Finance)   020 7220 0500

Richard Chambers / Sunila de Silva (Corporate Broking)

 

Regulatory Disclosures:

The following information regarding the appointment of Carol Thompson (née Johnson), aged 59, is disclosed under Schedule 2(g) of the AIM Rules for Companies:

Current directorships and/or partnerships:

Former directorships and/or partnerships (within the last five years):

 

AAA Rated Limited

Blixt Group Legal Services

Foresight Solar & Technology VCT plc

Hammer and Tongs Bike Lab Limited

Hammer & Tongs Performance Limited

 

 

 

 

 

 

There are no further disclosures required under Schedule 2(g) of the AIM Rules for Companies.

Please note that this announcement contains inside information as stipulated under the Market Abuse Regulation (EU no. 596/2014) as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR").

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAURANRANUKOAR
Date   Source Headline
3rd Jun 20267:00 amRNSNotice of AGM
1st Jun 20264:44 pmRNSResult of General Meeting
29th May 20262:03 pmRNSResult of Retail Offer and Update on Timing
13th May 20262:35 pmRNSRetail Offer
13th May 20262:30 pmRNSPlacing and Issue of Convertible Loan Notes
11th Feb 20263:26 pmRNSWithdrawal of Requisition
27th Jan 20267:00 amRNSRequisition of General Meeting
22nd Jan 20267:00 amRNSTrading Update
18th Sep 20257:00 amRNSInterim Results
8th Sep 20257:00 amRNS-RNotice of Investor Presentation
3rd Sep 20257:00 amRNSTrading Update
26th Aug 20257:00 amRNSAppointment of Non-Executive Chair
6th Aug 20257:00 amRNS-RAppointment of Chief Operating Officer
29th Jul 20257:00 amRNSTrading Update and Notice of Results
3rd Jun 20255:32 pmRNSResult of Annual General Meeting
3rd Jun 20257:00 amRNSAGM Trading Update
15th May 20257:00 amRNS-RYellowstone Advisory Private Investor Evening
12th May 20257:00 amRNSGrant of Options
8th May 20254:47 pmRNSAnnual Report and Notice of AGM
6th May 20257:00 amRNS2024 Annual Audited Results
2nd May 20257:00 amRNS-RNotice of Investor Presentation
1st May 20257:00 amRNSNotice of Annual Results
22nd Apr 20257:00 amRNSChange of Registered Office
25th Feb 20257:00 amRNSAppointment of Chief Executive Officer
31st Jan 20257:00 amRNSTrading Update
19th Sep 20247:00 amRNSInterim Results
7th Aug 20247:00 amRNSTrading Update and Notice of Results
3rd Jul 20247:00 amRNSAppointment of Non-Executive Directors
19th Jun 20242:24 pmRNSResult of AGM
19th Jun 20247:00 amRNSAGM Trading Update
10th May 20245:02 pmRNSAnnual Report and Notice of AGM
3rd May 202410:01 amRNSPublication of Annual Report
1st May 20247:00 amRNSFinal Results
18th Apr 202412:30 pmRNSBoard Changes
18th Apr 20247:00 amRNSNotice of Final Results
8th Mar 20247:00 amRNSDirector/PDMR Shareholding
27th Feb 20247:00 amRNSBoard Changes
22nd Jan 20247:00 amRNSTrading Update and Notice of Results
16th Oct 20234:15 pmRNSHolding(s) in Company
5th Oct 20237:00 amRNSDirector/PDMR Shareholding
19th Sep 20231:34 pmRNSReplacement: Interim results
19th Sep 20237:00 amRNSInterim results
4th Aug 20237:00 amRNSDirector/PDMR Shareholding
3rd Aug 20237:00 amRNSTrading update and Notice of Results
30th May 20235:25 pmRNSResults of AGM and Board Changes
30th May 20231:03 pmRNSAGM Statement
11th May 20232:20 pmRNSDirector Appointment
4th May 20235:15 pmRNSPosting of Annual Report and Notice of AGM
2nd May 20237:00 amRNSGrant and Surrender of Options
27th Apr 20237:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.